Human Health Holdings Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 2/6

Human Health Holdings kazançlarla iyi bir şekilde karşılanan, mevcut getirisi 3.59% olan temettü ödeyen bir şirkettir. Bir sonraki ödeme tarihi, temettüden önceki tarihi 30th December, 2024 olan 4th December, 2024 dir.

Anahtar bilgiler

3.6%

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisi	n/a
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	26.9%
Bir sonraki temettü ödeme tarihi	30 Dec 24
Eski temettü tarihi	04 Dec 24
Hisse başına temettü	HK$0.028
Ödeme oranı	44%

Son temettü ve geri alım güncellemeleri

Recent updates

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 25

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26

Yaklaşan Temettü Ödemesi

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: 1419 10 yıldan az bir süredir temettü ödüyor ve bu süre zarfında ödemeler dalgalı oldu.

Büyüyen Temettü: 1419 yalnızca 8 yıldır temettü ödüyor ve o zamandan beri ödemeler düştü.

Piyasaya Karşı Temettü Getirisi

Human Health Holdings Piyasaya Karşı Temettü Getirisi

1419 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (1419)	3.6%
Pazarın Alt %25'i (HK)	3.3%
Pazarın En İyi %25'i (HK)	8.1%
Sektör Ortalaması (Healthcare)	4.1%
Analist tahmini (1419) (3 yıla kadar)	n/a

Önemli Temettü: 1419 'in temettüsü ( 3.59% ), Hong Kong piyasasındaki temettü ödeyenlerin en alttaki %25'inden ( 3.3% ) daha yüksektir.

Yüksek Temettü: 1419 'in temettüsü ( 3.59% ), Hong Kong piyasasındaki temettü ödeyenlerin en üst %25'ine ( 8.06% ) kıyasla düşüktür.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Oldukça düşük ödeme oranı ( 43.9% ) ile 1419 'un temettü ödemeleri kazançlarla oldukça iyi bir şekilde karşılanıyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: 1419 temettü ödüyor ancak şirketin serbest nakit akışı yok.

Human Health Holdings Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 2/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Upcoming dividend of HK$0.30 per share

Upcoming dividend of HK$0.12 per share

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Recent updates

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Full year 2024 earnings released: EPS: HK$0.064 (vs HK$0.48 in FY 2023)

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

New minor risk - Profit margin trend

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Human Health Holdings Limited to Report First Half, 2023 Results on Feb 24, 2023

Investor sentiment improved over the past week

Upcoming dividend of HK$0.30 per share

Less than half of directors are independent

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Investor sentiment improved over the past week

Human Health Holdings Limited to Report Fiscal Year 2022 Results on Sep 29, 2022

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Human Health Holdings Limited to Report First Half, 2022 Results on Feb 25, 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.12 per share

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

First half 2021 earnings released: EPS HK$0.045 (vs HK$0.008 in 1H 2020)

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Human Health Holdings Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: HK$0.68

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

New 90-day low: HK$0.55

New 90-day low: HK$0.58

New 90-day low: HK$0.60

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Full year earnings released - HK$0.11 loss per share

Yaklaşan Temettü Ödemesi

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin